Perron Institute
The Perron Institute is dedicated to neurological research, focusing on understanding and treating neurological conditions through innovative research, collaboration, and community engagement. It aims to translate scientific discoveries into therapies and improve the quality of life for people with neurological disorders.
Industries
Nr. of Employees
medium (51-250)
Perron Institute
Ralph and Patricia Sarich Neuroscience Research Institute, QEII Medical Centre, Nedlands WA 6009, Australia
Products
Neuroprotective peptide candidate (preclinical)
A peptide therapeutic candidate demonstrated to reduce brain cell death in preclinical stroke models; compatibility with thrombolytic agents assessed and undergoing safety/toxicity verification prior to Phase I trials.
Ultra-high-throughput saliva molecular screening platform (pilot)
Saliva-based molecular testing workflow capable of processing large sample volumes rapidly for population-level viral surveillance with high reported accuracy in validation studies.
Neuroprotective peptide candidate (preclinical)
A peptide therapeutic candidate demonstrated to reduce brain cell death in preclinical stroke models; compatibility with thrombolytic agents assessed and undergoing safety/toxicity verification prior to Phase I trials.
Ultra-high-throughput saliva molecular screening platform (pilot)
Saliva-based molecular testing workflow capable of processing large sample volumes rapidly for population-level viral surveillance with high reported accuracy in validation studies.
Services
Outpatient clinical services for stroke, multiple sclerosis, Parkinson’s disease, motor neurone disease and other complex neurological disorders combined with research activities.
Remote stroke specialist consultations to support regional hospitals and provide rapid expert input for acute stroke management.
Access to a high-resolution multiphoton microscope and imaging infrastructure for deep tissue and cellular imaging available to researchers and industry via a booking system.
Ongoing recruitment and coordination of participants for clinical studies in neurological disorders including stroke, MS and Parkinson’s disease.
Pilot validation and ongoing evaluation of an ultra-high-throughput saliva molecular screening workflow for population surveillance of viral pathogens with rapid turnaround.
Outpatient clinical services for stroke, multiple sclerosis, Parkinson’s disease, motor neurone disease and other complex neurological disorders combined with research activities.
Remote stroke specialist consultations to support regional hospitals and provide rapid expert input for acute stroke management.
Access to a high-resolution multiphoton microscope and imaging infrastructure for deep tissue and cellular imaging available to researchers and industry via a booking system.
Ongoing recruitment and coordination of participants for clinical studies in neurological disorders including stroke, MS and Parkinson’s disease.
Pilot validation and ongoing evaluation of an ultra-high-throughput saliva molecular screening workflow for population surveillance of viral pathogens with rapid turnaround.
Expertise Areas
- Translational neuroscience
- Clinical trial recruitment and management
- Neurodegenerative disease research
- Brain stimulation and neuromodulation (rTMS)
Key Technologies
- Antisense oligonucleotides
- Repetitive transcranial magnetic stimulation (rTMS)
- Spatial transcriptomics
- Next-generation sequencing
News & Updates
Celebration hosted by the Governor of Western Australia, Kim Beazley, to mark the 40th anniversary of the Perron Institute, attended by government officials, industry leaders, donors, and researchers.
The Perron Institute launched a radio campaign with commercials playing throughout February and March 2022, to raise awareness about their work.
The Medical Director, Professor David Blacker, shared his personal story about living with Parkinson’s disease to raise awareness on World Brain Day.
PhD student Anastazja Gorecki will be based at Johns Hopkins University in Baltimore, Maryland, to study gut inflammation and Parkinson’s disease as part of her Fulbright Scholarship.
Research by the Perron Institute uncovered new pathways for understanding how non-invasive brain stimulation techniques like rTMS work.
Research at Perron Institute and UWA identified a new pathway in cells that respond to exercise, which could lead to new therapies for neurological conditions.
Celebration hosted by the Governor of Western Australia, Kim Beazley, to mark the 40th anniversary of the Perron Institute, attended by government officials, industry leaders, donors, and researchers.
The Perron Institute launched a radio campaign with commercials playing throughout February and March 2022, to raise awareness about their work.
The Medical Director, Professor David Blacker, shared his personal story about living with Parkinson’s disease to raise awareness on World Brain Day.
PhD student Anastazja Gorecki will be based at Johns Hopkins University in Baltimore, Maryland, to study gut inflammation and Parkinson’s disease as part of her Fulbright Scholarship.
Research by the Perron Institute uncovered new pathways for understanding how non-invasive brain stimulation techniques like rTMS work.
Research at Perron Institute and UWA identified a new pathway in cells that respond to exercise, which could lead to new therapies for neurological conditions.